VIDA Diagnostics

Medical Devices & EquipmentSeries CCoralville, USvidalung.ai

Latest round

Series C

Last raised

Apr 2020

Total raised

$19M

Investors

12

About VIDA Diagnostics

Based in Iowa, US and founded in 2004, VIDA Diagnostics, Inc. operates as a developer of LungPrint®, an Artificial Intelligence-powered quantitative pulmonary analysis software for the treatment of chronic obstructive pulmonary disease (COPD), emphysema, lung cancer, asthma, and COVID-19. The company was co-founded by Eric A. Hoffman and Joseph M. Vida provides two solutions namely VIDA Insights and VIDA Discovery. VIDA Insights combines data and machine learning to provide quantified lung measures and novel visualizations. It has the ability to detect the disease early, conducts the precise diagnosis, and gives systematic tracking and personalized treatments. VIDA Discovery modernizes the clinical trial process by providing quality, quantitative CT imaging analysis for all major lung and respiratory diseases. The company recently received 510(k) clearance from the Food and Drug Administration (FDA) for enhancements to its LungPrint solution, including automated deep learning-based lung and lobe segmentation algorithms. The clearance further proves the quality and clinical efficacy of Vida’s artificial intelligence (AI)-powered precision imaging and analytics solutions.

Who invested in VIDA Diagnostics

12 investors across 3 rounds

See all investors in VIDA Diagnostics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Apr 15, 2020

    Amount

    $2M

    Investors

    Locked

  2. Series C

    Mar 12, 2020

    Amount

    $12M

    Investors

    Locked

  3. Series B

    Dec 20, 2016

    Amount

    $5.1M

    Investors

    Locked

Questions about VIDA Diagnostics

Who invested in VIDA Diagnostics?

VIDA Diagnostics has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has VIDA Diagnostics raised?

VIDA Diagnostics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did VIDA Diagnostics last raise money?

VIDA Diagnostics's most recent round on record is a Series C, in Apr 2020.

What does VIDA Diagnostics do?

Based in Iowa, US and founded in 2004, VIDA Diagnostics, Inc.

Where is VIDA Diagnostics headquartered?

VIDA Diagnostics is headquartered in Coralville, US.

Which VCs invest in companies like VIDA Diagnostics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at VIDA Diagnostics's stage. Their profiles are linked below.

Raising like VIDA Diagnostics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.